This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tony's Most Recent Article

Options Trade Into Ziopharm's Sarcoma Drug Study Results

02/26/13 - 11:00 AM EST

Options expert Tony Pelz says options are the best way to trade Ziopharma's looming palifosamide data.

read more >

Other Articles by Tony

Free Reports

Dynavax Options Trade for Heplisav FDA Approval Decision

02/12/13 - 08:30 AM EST

Options expert Tony Pelz offers investors a way to use options to trade Dynavax's upcoming FDA decision.

read more >
Alexza Pharma: Premium Selling Options Strategy

12/12/12 - 11:27 AM EST

A new options trade for Alexza going into an FDA drug approval decision.

read more >
Amicus: Bullish Options Trade Into Clinical Trial Catalysts

12/04/12 - 09:05 AM EST

Contributor Tony Pelz offers an options trade for those who believe Amicus shares are going higher.

read more >
Dynavax: Speculative Upside Options Trade

11/20/12 - 07:31 AM EST

How to use options to play a possible run-up in Dynavax prior to the FDA's approval decision.

read more >
Exelixis: New Drug Approval Options Trade

11/06/12 - 08:00 AM EST

Options wizard Tony Pelz suggests another way to trade Exelixis's FDA drug approval decision.

read more >
Eli Lilly: Bearish Options Trade

11/01/12 - 10:01 AM EDT

Tony Pelz offers a short-term options trade to take advantage of end-of-year selling in Eli Lilly.

read more >
Ziopharm: Options Trade for Phase III Data

10/22/12 - 08:30 AM EDT

How to play the high-risk release of results from Ziopharm's phase III study.

read more >
How to Hedge Profits in Sarepta Therapeutics

10/15/12 - 09:00 AM EDT

Options guru Tony Pelz offers options trades for those who want to protect their Sarepta profits.

read more >
NPS Pharma: Bullish Options Trade Into the Gattex FDA Panel

10/08/12 - 08:00 AM EDT

Biotech options expert Tony Pelz recommends a bullish options trade for the Oct. 16 Gattex FDA panel.

read more >
Page 1 of 2
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs